Position in ALNY
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$3,120,104
-$766,527 QoQ
Shares Held
9,430
-3.5% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 98.95015906680807.ToString("F0")%
Shared 0.ToString("F0")%
None 1.0498409331919405.ToString("F0")%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BLAIR WILLIAM & CO/IL holds $126,358,113 across 56 Biotechnology names. ALNY ranks #8 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
864,329 | $45,169,833 | |
| 2 | ARGX |
Argenx SE
|
22,407 | $16,362,711 | |
| 3 | VKTX |
Viking Therapeutics, Inc.
|
371,119 | $12,076,212 | |
| 4 | EXEL |
Exelixis, Inc.
|
193,238 | $8,287,977 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
16,541 | $7,386,218 | |
| 6 | SLDB |
Solid Biosciences Inc.
|
651,216 | $4,688,755 | |
| 7 | NGNE |
Neurogene Inc.
|
168,218 | $3,391,274 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
9,430 | $3,120,104 |
All Filings in ALNY
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,120,104 | 9,430 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $3,886,631 | 9,774 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $4,671,264 | 10,244 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $3,453,945 | 10,592 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $2,991,281 | 11,078 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $2,814,778 | 11,962 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $3,667,250 | 13,334 | Shares | Sole | 2024-11-12 | |
| No filing history on record for this holder in this stock. | ||||||